Type I Allergy to Cow Milk Proteins in Adults

1993 ◽  
Vol 102 (4) ◽  
pp. 399-407 ◽  
Author(s):  
P. Stöger ◽  
B. Wüthrich
Keyword(s):  
Milk Proteins ◽  
Cow Milk ◽  
Type I ◽  
Type I Allergy

Type I Allergy to Egg and Milk Proteins: Comparison of Skin Prick Tests with Nasal, Buccal and Gastric Provocation Tests

1985 ◽  
Vol 77 (1-2) ◽  
pp. 171-173 ◽  
Author(s):  
P.L. Amlot ◽  
R. Urbanek ◽  
L.J.F. Youlten ◽  
M. Kemeny ◽  
M.H. Lessof
Keyword(s):  
Milk Proteins ◽  
Type I ◽  
Type I Allergy ◽  
Provocation Tests ◽  
Skin Prick Tests

Formalin-Fixed Staphylococcus aureus Particles Prevent Allergic Sensitization in a Murine Model of Type I Allergy

2007 ◽  
Vol 144 (3) ◽  
pp. 183-196 ◽  
Author(s):  
Karina Gisch ◽  
Nadine Gehrke ◽  
Matthias Bros ◽  
Christina Priesmeyer ◽  
Jürgen Knop ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Murine Model ◽  
Allergic Sensitization ◽  
Type I ◽  
Type I Allergy ◽  
Formalin Fixed

scholarly journals Post translational modifications of milk proteins in geographically diverse goat breeds

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
P. K. Rout ◽  
M. Verma
Keyword(s):  
Protein Function ◽  
Whey Proteins ◽  
Milk Proteins ◽  
Goat Milk ◽  
Peptide Sequence ◽  
Cow Milk ◽  
Post Translational Modification ◽  
Post Translational Modifications ◽  
Functional Roles ◽  
Dpp Iv

AbstractGoat milk is a source of nutrition in difficult areas and has lesser allerginicity than cow milk. It is leading in the area for nutraceutical formulation and drug development using goat mammary gland as a bioreactor. Post translational modifications of a protein regulate protein function, biological activity, stabilization and interactions. The protein variants of goat milk from 10 breeds were studied for the post translational modifications by combining highly sensitive 2DE and Q-Exactive LC-MS/MS. Here we observed high levels of post translational modifications in 201 peptides of 120 goat milk proteins. The phosphosites observed for CSN2, CSN1S1, CSN1S2, CSN3 were 11P, 13P, 17P and 6P, respectively in 105 casein phosphopeptides. Whey proteins BLG and LALBA showed 19 and 4 phosphosites respectively. Post translational modification was observed in 45 low abundant non-casein milk proteins mainly associated with signal transduction, immune system, developmental biology and metabolism pathways. Pasp is reported for the first time in 47 sites. The rare conserved peptide sequence of (SSSEE) was observed in αS1 and αS2 casein. The functional roles of identified phosphopeptides included anti-microbial, DPP-IV inhibitory, anti-inflammatory and ACE inhibitory. This is first report from tropics, investigating post translational modifications in casein and non-casein goat milk proteins and studies their interactions.

scholarly journals Impedance-Based Living Cell Analysis for Clinical Diagnosis of Type I Allergy

Sensors ◽  
2017 ◽  
Vol 17 (11) ◽  
pp. 2503 ◽  
Author(s):  
Reiko Irifuku ◽  
Yuhki Yanase ◽  
Tomoko Kawaguchi ◽  
Kaori Ishii ◽  
Shunsuke Takahagi ◽  
...  
Keyword(s):  
Clinical Diagnosis ◽  
Living Cell ◽  
Type I ◽  
Cell Analysis ◽  
Type I Allergy

scholarly journals Clinical diagnosis of type I allergy by means of SPR imaging with less than a microliter of peripheral blood

2014 ◽  
Vol 2 ◽  
pp. 43-48 ◽  
Author(s):  
Yuhki Yanase ◽  
Takaaki Hiragun ◽  
Tetsuji Yanase ◽  
Tomoko Kawaguchi ◽  
Kaori Ishii ◽  
...  
Keyword(s):  
Clinical Diagnosis ◽  
Peripheral Blood ◽  
Type I ◽  
Type I Allergy ◽  
Spr Imaging

mRNA vaccination as a safe approach for specific protection from type I allergy

2012 ◽  
Vol 11 (1) ◽  
pp. 55-67 ◽  
Author(s):  
Richard Weiss ◽  
Sandra Scheiblhofer ◽  
Elisabeth Roesler ◽  
Esther Weinberger ◽  
Josef Thalhamer
Keyword(s):  
Type I ◽  
Type I Allergy ◽  
Safe Approach

scholarly journals Prevention of Transcutaneous Sensitization to Cow Milk Proteins in Infants with Atopic Dermatitis: Cohort Study

2020 ◽  
Vol 19 (6) ◽  
pp. 538-544
Author(s):  
Nikolay N. Murashkin ◽  
Svetlana G. Makarova ◽  
Stepan G. Grigorev ◽  
Dmitri V. Fedorov ◽  
Roman A. Ivanov ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Maintenance Therapy ◽  
Milk Proteins ◽  
Allergic Diseases ◽  
Specific Ige ◽  
Dispersion Analysis ◽  
Cow Milk ◽  
Group 2 ◽  
Group 1

Background. Malformations in epidermal barrier in children with atopic dermatitis (AD) can cause transcutaneous sensitization with further development of allergic diseases that can worsen the AD course and significantly reduces patients’ quality of life.Objective. The aim of the study was to determine the effect of topical treatment and maintenance therapy with pimecrolimus 1% cream (PIM) and topical glucocorticosteroids (tGCS) in infants with AD on reducing the risk of developing transcutaneous sensitization (due to the levels of specific IgE to the cow milk protein over time) and on reducing the disease severity (by the EASI scale).Methods. The study included children aged from 1 to 4 months with early manifestations of moderate and severe AD. The severity of AD was estimated via the EASI scale at start of observation, then at 6, 9 and 12 months of life. The class and level of specific IgE to cow milk proteins (CMP) were determined by the ImmunoCAP method at the point of enrolment and at the ages of 6 and 12 months. Statistical analysis of studied indicators dynamics and their comparison in research groups was carried out using multifactorial dispersion analysis.Results. The study included 36 patients. All patients have received standard tGCS therapy in combination with emollients (wet wrap) for 10 days. The maintenance therapy was prescribed in postacute period. It included topical calcineurin inhibitor PIM 2 times/day for 3 months, then double application (morning/evening) 3 times/week up to the age of 1 year old (group 1). Other group had maintenance therapy — tGCS2 times/week for 3 months, and then at AD aggravation (group 2). Group 1 has shown lower level of sensitization to CMP at the age of 6 and 12 months and more significant decrease in AD severity according to EASI scale compared to group 2.Conclusion. The treatment with PIM is effective in therapy of AD and prevention of transcutaneous sensitization in infants.

Sign in / Sign up

Export Citation Format

Share Document